527 related articles for article (PubMed ID: 24029433)
1. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
Perri MB; Hershberger E; Ionescu M; Lauter C; Zervos MJ
Diagn Microbiol Infect Dis; 2002 Apr; 42(4):269-71. PubMed ID: 12007445
[TBL] [Abstract][Full Text] [Related]
4. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
5. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
6. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
7. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
Das A; Banerjee T; Anupurba S
Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Weinstein MP
J Clin Microbiol; 2001 Jul; 39(7):2729-31. PubMed ID: 11427608
[TBL] [Abstract][Full Text] [Related]
10. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.
Shrestha NK; Chua JD; Tuohy MJ; Wilson DA; Procop GW; Longworth DL; Isada CM; Hall GS
Scand J Infect Dis; 2003; 35(1):12-4. PubMed ID: 12685877
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
Tang HJ; Chen CC; Cheng KC; Toh HS; Su BA; Chiang SR; Ko WC; Chuang YC
J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics.
Butcu M; Akcay SS; Inan AS; Aksaray S; Engin DO; Calisici G
J Infect Chemother; 2011 Aug; 17(4):575-8. PubMed ID: 21287226
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.
Farina C; Russello G; Chinello P; Pasticci MB; Raglio A; Ravasio V; Rizzi M; Scarparo C; Vailati F; Suter F;
Chemotherapy; 2011; 57(5):426-33. PubMed ID: 22122863
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.
Pereira GH; Müller PR; Zanella RC; de Jesus Castro Lima M; Torchio DS; Levin AS
Am J Infect Control; 2010 Jun; 38(5):406-9. PubMed ID: 20006408
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India.
Tripathi A; Shukla SK; Singh A; Prasad KN
Indian J Med Microbiol; 2016; 34(1):38-45. PubMed ID: 26776117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
